@article{oai:tsukuba.repo.nii.ac.jp:00054772,
 author = {山内, 一由 and YAMAUCHI, Kazuyoshi and Usami, Yoko and Ichihara, Kiyoshi and Uehara, Takeshi and Sugano, Mitsutoshi and Ishimine, Nau and Kawasaki, Kenji and Hamano, Hideaki and Honda, Takayuki},
 journal = {Clinica Chimica Acta},
 month = {Feb},
 note = {Background
IgG4-related disease (IgG4-RD) is a new syndrome characterized by elevated serum IgG4 concentration and tissue infiltration of IgG4-positive plasma cells. Here, we evaluated the analytical performance of a new IgG4 assay reagent featuring a wide dynamic range, highly specific monoclonal antibody, and the reversed passive latex agglutination assay and determined the IgG4 reference interval (RI) for the Japanese population.

Methods
Performance evaluations were conducted on precision, linearity, sensitivity, interference, and method comparison with The Binding Site (TBS) and Siemens reagents. The RI was derived by the parametric method from 619 apparently healthy Japanese 18 to 65 years of age.

Results
Between-day precisions ranged from 1.99 to 5.52 CV%. Linearity was confirmed up to 5.0 g/l. The limit of quantitation was 0.085 g/l. Interfering substances did not significantly influence values. Method comparison among the 3 reagents yielded correlation coefficients between 0.973 and 0.988. Values for the new reagent matched those of TBS reagent except at a higher concentration range, where reactivity dissociated. The RI was 0.11–1.21 g/l without distinction by sex and age.

Conclusion
The novel IgG4 assay reagent demonstrated satisfactory analytical performance for clinical use. Because of matched value with TBS reagent at low concentrations, it is possible to use the IgG4-RD cut-off value determined by TBS reagent.},
 pages = {136--141},
 title = {Evaluation of a novel serum IgG4 assay and determination of reference interval for the Japanese population},
 volume = {501},
 year = {2020},
 yomi = {ヤマウチ, カズヨシ}
}